Health News

Outsourcing In Clinical Trials Southern California, September 24-25, 2013, La Jolla, CA

Date: Jul-17-2013
As a result of numerous requests to bring this series to the region, September 2013 will see the launch of a specifically tailored event catering to this life science hub. With an agenda covering topics relevant to pharma, biotech, virtual and medical device companies, this event offers a unique opportunity to tailor your visit and take away the most valuable and relevant information and network with specific, high profile contacts...

6th Annual Healthcare Deal Making Summit, September 24 - 26, 2013, Nashville, TN

Date: Jul-17-2013
With the implementation of Affordable Care Act moving rapidly forward, the U.S. healthcare industry is faced with a daunting range of strategic choices. Revolutions in Medicare reimbursement will be balanced by an influx of millions of new Medicaid enrollments, while the demands of coordinated care are driving new technological advances and a shift into California-style managed care medicine nationwide...

"Take Later Retirement" For Lower Dementia Risk

Date: Jul-17-2013
A very large study of self-employed people living in France finds those who retired later had a lower risk of being diagnosed with dementia, in line with the idea that you either "use it or lose it." Carole Dufouil of the Bordeaux School of Public Health, and colleagues, found that the risk of being diagnosed with dementia went down for each year of working longer. The study appears to confirm earlier research that suggests lifelong mental stimulation and challenge may protect against Alzheimer's and other forms of dementia...

Weill Cornell Presents Updated Results From Phase 3 Trial Of IVIG For Alzheimer's Disease

Date: Jul-17-2013
Weill Cornell Medical College neurologist Dr. Norman Relkin reported new findings from the Phase 3 clinical trial of IVIG (intravenous immunoglobulin) in mild to moderate Alzheimer's disease at the Alzheimer's Association International Conference (AAIC) in Boston, Mass. While the primary study outcomes were negative, observations from the subgroup analyses include whether there may be a dose-dependent reduction of beta amyloid in the blood and brain of IVIG-treated Alzheimer's patients who have the ApoE4 genotype.   IVIG is a mixture of antibodies derived from the blood of healthy donors...

Higher Incidence Of Morbidity In Obese Children In Sweden Than In Germany

Date: Jul-17-2013
More than one in six children in Sweden who are obese also have pre-diabetes. This has been demonstrated in a large study of more than 35,000 children from Sweden and Germany conducted at Karolinska Institutet and published in the scientific periodical International Journal of Obesity. The study, which is based on a collaboration between the national childhood obesity registry in Sweden, BORIS, and its German counterpart, APV, reveals that the incidence of pre-diabetes is three times higher in children in Sweden than in Germany...

Benefits Of Pradaxa Maintained In Difficult To Treat Patients With Atrial Fibrillation And Symptomatic Heart Failure

Date: Jul-17-2013
Published in the European Journal of Heart Failure[1], results from a new sub-analysis of the RE-LY®i trial demonstrate important benefits of Pradaxa® (dabigatran etexilate) over warfarin in difficult-to-treat patients with non-valvular atrial fibrillation (AF) and previous symptomatic heart failure (HF)...

Astronomy Technology Used For Early Detection Of AMD - The Developed World's Leading Cause Of Sight Loss

Date: Jul-17-2013
Engineers used to designing state of the art instruments for ground and space based telescopes are now applying their expertise to the development of a diagnostic test for the developed world's most common form of sight loss in adults, Age-Related Macular Degeneration (AMD). AMD leads to the loss of the vision used when looking at something directly ahead, at another person for example, or when reading or watching television. In the UK alone, by 2020 the number of AMD sufferers is expected to rise to 750,000 and currently more than 1% of over 60s suffer from some sort of AMD...

UK Festival-Goers Encouraged To Protect Their Eyes This Summer

Date: Jul-17-2013
The thousands of Brits taking advantage of the sun by visiting festivals this summer are being warned to protect their eyesight from over exposure to UV rays by independent opticians.  An estimated 135,000 people attended Glastonbury alone this year and thousands more are gearing up to attend the biggest events of the summer calendar, including Global Gathering at the end of July, V fest in August and Bestival in September...

Data Shows Zonegran(R) (Zonisamide) Is Well-Tolerated By Elderly Patients With Partial Epilepsy

Date: Jul-17-2013
Pooled-analysis shows zonisamide as an effective partial epilepsy treatment for the elderly, as well as adults. Results from a pooled-analysis, published today in Acta Neurologica Scandinavica, show Zonegran(R) (zonisamide) is a well-tolerated treatment for partial seizures with or without secondary generalisation in the elderly population (65 years and above), when used as a monotherapy or adjunctive (add-on) therapy...

New Report Highlights Need To Address Long-Term Care Demands In The US

Date: Jul-17-2013
Today, AARP Public Policy Institute, National Association of States United for Aging and Disabilities (NASUAD) and Health Management Associates (HMA) released a new report highlighting the challenges facing states in providing long-term services and supports (LTSS)...